Vera Therapeutics, Inc.VERANASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-4.92%
↑ 91% above average
Average (22q)
-54.93%
Historical baseline
Range
High:89.01%
Low:-861.32%
Volatility
-1730.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -4.92% |
| Q2 2025 | -48.05% |
| Q1 2025 | -19.04% |
| Q4 2024 | 6.88% |
| Q3 2024 | -38.34% |
| Q2 2024 | -18.76% |
| Q1 2024 | -10.63% |
| Q4 2023 | -27.61% |
| Q3 2023 | 0.29% |
| Q2 2023 | 32.95% |
| Q1 2023 | 7.31% |
| Q4 2022 | -31.44% |
| Q3 2022 | -66.15% |
| Q2 2022 | 13.06% |
| Q1 2022 | -1.41% |
| Q4 2021 | -121.35% |
| Q3 2021 | -121.44% |
| Q2 2021 | 27.09% |
| Q1 2021 | 89.01% |
| Q4 2020 | -861.32% |
| Q3 2020 | -23.75% |
| Q2 2020 | -45.68% |
| Q1 2020 | 0.00% |